| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/11/2008 | CN101195003A Proprietary Chinese medicine for treating apoplexy and sequela |
| 06/11/2008 | CN101194996A Chinese medicine ejection preparation and method for preparing the same |
| 06/11/2008 | CN101194990A Chinese medicine ointment for treating ache of neck, shoulder, waist and leg |
| 06/11/2008 | CN101194982A Antidepressive Chinese medicine composition and method of preparing the same |
| 06/11/2008 | CN101194967A Hypoglossis buccal tablets for treating headache and method for preparing the same |
| 06/11/2008 | CN101194966A Buccal tablets for treating headache and method for preparing the same |
| 06/11/2008 | CN101194965A Mastication tablet for treating headache and method for preparing the same |
| 06/11/2008 | CN101194964A Coated tablet for treating headache and method for preparing the same |
| 06/11/2008 | CN101194963A Process for preparing medicine for treating headache |
| 06/11/2008 | CN101194962A Pill for treating headache and method for preparing the same |
| 06/11/2008 | CN101194961A Aerosol for treating headache and method for preparing the same |
| 06/11/2008 | CN101194960A Oral liquid for treating headache and method for preparing the same |
| 06/11/2008 | CN101194959A Capsule for treating headache and method for preparing the same |
| 06/11/2008 | CN101194958A Method for preparing decocted ointment for treating headache |
| 06/11/2008 | CN101194945A Tablet for treating headache and method for preparing the same |
| 06/11/2008 | CN101194934A Method for abstracting active compound rich in echinacoside and feltwort glycoside |
| 06/11/2008 | CN101194926A Tea for giving up smoking |
| 06/11/2008 | CN101194922A Acesodyne medicament dropping pills and method for preparing the same |
| 06/11/2008 | CN101194910A Dropping pills containing acegastrodine and method for preparing the same |
| 06/11/2008 | CN101194909A Dropping pills containing gastrodine and method for preparing the same |
| 06/11/2008 | CN101194908A Dropping pills containing lorazepam and method for preparing the same |
| 06/11/2008 | CN101194903A Dropping pills containing Isocarboxazid and method for preparing the same |
| 06/11/2008 | CN101194901A Use of agomelatine to obtain medication aimed at treating Smith-Magenis syndrome |
| 06/11/2008 | CN101194899A Use of patchouli alcohol in preparing medicament for preventing and controlling senile dementia |
| 06/11/2008 | CN101194716A Health care beverage for treating neurasthenic and preparing method thereof |
| 06/11/2008 | CN100393721C N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto |
| 06/11/2008 | CN100393719C Process for preparing an anticholinergic |
| 06/11/2008 | CN100393716C Coumarin derivatives, and their preparing method and use as alpha, receptor agonist |
| 06/11/2008 | CN100393703C 1,2,3,4-tetrahydroisoquinoline derivatives |
| 06/11/2008 | CN100393351C Use of composition in preparing medicament for preventing and treating anypnia |
| 06/11/2008 | CN100393339C Kidney-tonifying brain-invigorating medicine and preparation process thereof |
| 06/11/2008 | CN100393246C Infant formula supplemented with phospholipids |
| 06/11/2008 | CN100393226C Tobacco poison eliminating Sanshen health tea |
| 06/10/2008 | US7385083 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity |
| 06/10/2008 | US7385059 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | US7385042 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 06/10/2008 | US7384981 Preparation for improving the action of receptors |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384961 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384955 N-[1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-2,2-dimethyl-propanamide; cannabinoid CB1/CB2 receptor agonists; analgesic; in therapy, in particular in the management of pain |
| 06/10/2008 | US7384952 1-(3-ethoxybenzyl)-4-[4-[4-[2-(dimethylamino)ethoxy]benzoyl]piperazin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine; small conductance potassium channel (SK channel) blocking activity; gastrointestinal disorders |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384949 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 06/10/2008 | US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 06/10/2008 | US7384943 Substituted chroman derivatives |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384941 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| 06/10/2008 | US7384934 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania |
| 06/10/2008 | US7384931 Constrained compounds as CGRP-receptor antagonists |
| 06/10/2008 | US7384930 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384653 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 06/10/2008 | US7384651 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/10/2008 | US7384632 for prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy |
| 06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | CA2371827C Amide compounds for the potentiation of cholinergic activity |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2345121C Pharmaceutical composition for the treatment of acute disorders |
| 06/10/2008 | CA2326517C New galenic preparations of meloxicam for oral administration |
| 06/10/2008 | CA2302586C Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 06/10/2008 | CA2286330C Anti-vegf antibodies |
| 06/10/2008 | CA2250075C Methods for diagnosing and treating alzheimer's disease |
| 06/10/2008 | CA2250010C Denaturants for sympathomimetic amine salts |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/08/2008 | CA2572004A1 Tablets comprising entacapone and crospovidone |
| 06/06/2008 | CA2609580A1 Composition for promoting cognitive attributes |
| 06/05/2008 | WO2008067390A2 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
| 06/05/2008 | WO2008067177A2 Methods for the treatment of alcohol abuse, addiction and dependency |
| 06/05/2008 | WO2008067167A1 Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 06/05/2008 | WO2008067120A2 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 06/05/2008 | WO2008066750A1 Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
| 06/05/2008 | WO2008066494A1 THERAPEUTIC USES OF β-ANTAGONISTS |
| 06/05/2008 | WO2008066185A1 Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation |
| 06/05/2008 | WO2008066184A1 Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue in donepezil-containing skin adhesive preparation |
| 06/05/2008 | WO2008066183A1 Skin adhesive preparation comprising stabilized donepezil |
| 06/05/2008 | WO2008066180A1 Skin adhesive preparation comprising stabilized donepezil |
| 06/05/2008 | WO2008066179A1 Percutaneous absorption preparation |
| 06/05/2008 | WO2008066151A1 Novel curcumin derivative |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065666A2 Uses of incensole, incensole acetate and derivatives thereof |
| 06/05/2008 | WO2008065626A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
| 06/05/2008 | WO2008065500A2 Heteroaryl amides as type i glycine transport inhibitors |
| 06/05/2008 | WO2008065386A1 Treatment of disease |
| 06/05/2008 | WO2008065155A1 Cdk inhibitors for treating pain |
| 06/05/2008 | WO2008065021A1 Diaminocyclohexane and diaminocyclopentane derivatives |
| 06/05/2008 | WO2008064854A1 Drug preparation of tramadol and acetaminophen |
| 06/05/2008 | WO2008064615A2 Crystalline and amorphous forms of rimonabant and processes for obtaining them |
| 06/05/2008 | WO2008064552A1 Use of cholinesterase for manufacturing an anti-tachykinins medicament |
| 06/05/2008 | WO2008064432A1 Polycyclic molecular compounds |
| 06/05/2008 | WO2008064401A1 Improved peptide composition |
| 06/05/2008 | WO2008005295A3 Modulators of muscarinic receptors |